This example shows a sample report table, trial design, and results data dataset for Study #123 for the determination of the in vitro genotoxicity potential of tobacco products in using the in vitro Micronucleus Assay. This sample study
Expand |
---|
title | Sample Report Table for Study 123 |
---|
|
|
Dataset wrap |
---|
Rowcaps |
---|
Rows 1-2: | Show two records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records, since both GLP Types apply for this example study. | Row 8: | Shows that the sponsor's study reference ID is not applicable. | Rows 9-12: | Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID = 1). The Study Director is associated with the Test Facility. |
|
Dataset2 |
---|
Row | STUDYID | ASSAYID | DOMAIN | TSSEQ | TSGRPID | TSPARMCD | TSPARM | TSVAL | TSVALNF |
---|
1 | 123 | NRU | TS | 1 |
| GLPTYP | Good Laboratory Practice Type | FDA |
|
---|
2 | 123 | NRU | TS | 2 |
| GLPTYP | Good Laboratory Practice Type | OECD |
|
---|
3 | 123 | NRU | TS | 1 |
| STSTDTC | Study Start Date | 2022-05-25 |
|
---|
4 | 123 | NRU | TS | 1 |
| STITLE | Study Title | Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay |
|
---|
5 | 123 | NRU | TS | 1 |
| SNDIGVER | SEND Implementation Guide Version | TOBACCO IMPLEMENTATION GUIDE VERSION 1.0 |
|
---|
6 | 123 | NRU | TS | 1 |
| SNDCTVER | SEND Controlled Terminology Version | SEND Terminology 2021-09-30 |
|
---|
7 | 123 | NRU | TS | 1 |
| SSPONSOR | Sponsor Organization | Example Sponsor Inc. |
|
---|
8 | 123 | NRU | TS | 1 |
| SPREFID | Sponsor Study Reference ID |
| NOT APPLICABLE |
---|
9 | 123 | NRU | TS | 1 | 1 | TSTFNAM | Test Facility Name | Example Test Lab Name |
|
---|
10 | 123 | NRU | TS | 1 | 1 | TSTFLOC | Test Facility Location | 10 Somewhere Street, Montgomery, AL 10000 |
|
---|
11 | 123 | NRU | TS | 1 | 1 | TFCNTRY | Test Facility Country | USA |
|
---|
12 | 123 | NRU | TS | 1 | 1 | STDIR | Study Director | Dr. R. Smith |
|
---|
13 | 123 | NRU | TS | 1 |
| GLPFL | GLP Flag | Y |
|
---|
14 | 123 | NRU | TS | 1 |
| ASTD | Assay Standard | NIH Publication OECD GUIDELINE FOR THE TESTING OF CHEMICALS No. 07-4519487 |
|
---|
15 | 123 | NRU | TS | 1 |
| ASTDV | Assay Standard Version | 200629-July-112016 |
|
---|
16 | 123 | NRU | TS | 1 |
| SSTYP | Study Type | GENOTOXICITY IN VITRO |
|
---|
17 | 123 | NRU | TS | 1 |
| SSSTYP | Study Sub Type | In Vitro Neutral Red UptakeMICRONUCLEUS TEST |
|
---|
18 | 123 | NRU | TS | 1 |
| SPECIES | Species | HamsterHUMAN |
|
---|
19 | 123 | NRU | TS | 1 |
| TESTSYS | Test System | CHO |
|
---|
|
|
This example trial set dataset, tx.xpt, shows information about the test conditions for set A1 and A2 in this example study, 123. Set A1 and A2 can be seen in the first and second rows respectively of Table 1 in the Sample Report table for Study 123 (above). For brevity, the trial sets dataset, tx.xpt, and the findings dataset, gt.xpt do not show information for any other sets. Fully formed datasets for this example study would include information about the test conditions and findings for all sets.
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-23: | Show trial set parameters and trial set values that comprise the test conditions for trial set A1. Set A1 is the data for the negative control (concentration 0) with short term exposure and metabolic activation S9. The applicant has chosen to given a long name (SET) equal to "ST+S9_C0". Set A1 is associated with the first row in the sample report table for study 123. | Rows 24-46: | Show trial set parameters and trial set values that comprise the test conditions for trial set A2. Set A2 is the data for the short term exposure with metabolic activation S9 at a concentration of 1250 ug/ml. The applicant has chosen to give the set a long name (SET) equal to "ST+S9_C1250". Set A2 is associated with the second row in the sample report table for study 123. |
|
Dataset2 |
---|
Row | STUDYID | GNTXAID | DOMAIN | SETCD | SET | TXSEQ | TXPARMCD | TXPARM | TXVAL |
---|
1 | 123 | MNvit | TX | A1 | ST+S9_C0 | 2 | METACT | Metabolic Activation | +S9 | 2 | 123 | MNvit | TX | A1 | ST+S9_C0 | 3 | METACTFL | Y/N presence of metabolic activation | Y |
---|
3 | 123 | MNvit | TX | A1 | ST+S9_C0 | 4 | TRTDMIN | Treatment Duration Minimum | 3 |
---|
4 | 123 | MNvit | TX | A1 | ST+S9_C0 | 5 | TRTDTRG | Treatment Duration Target | 3.5 |
---|
5 | 123 | MNvit | TX | A1 | ST+S9_C0 | 6 | TRTDMAX | Treatment Duration Maximum | 4 |
---|
6 | 123 | MNvit | TX | A1 | ST+S9_C0 | 7 | TRTDU | Treatment Duration Unit | HOURS | 7 | 123 | MNvit | TX | A1 | ST+S9_C0 | 8 | RCVDMIN | Recovery Duration Minimum | 23.5 | 8 | 123 | MNvit | TX | A1 | ST+S9_C0 | 9 | RCVDTRG | Recovery Duration Target | 24 | 9 | 123 | MNvit | TX | A1 | ST+S9_C0 | 10 | RCVDMAX | Recovery Duration Maximum | 24.5 | 10 | 123 | MNvit | TX | A1 | ST+S9_C0 | 11 | RCVDU | Recovery Duration Unit | HOURS | 11 | 123 | MNvit | TX | A1 | ST+S9_C0 | 12 | INCBTMP | Incubation Temperature | 37 | 12 | 123 | MNvit | TX | A1 | ST+S9_C0 | 13 | INCBTMPU | Incubation Temperature Unit | C | 13 | 123 | MNvit | TX | A1 | ST+S9_C0 | 14 | HUMID | Atmospheric Relative Humidity Percent | 50 | 14 | 123 | MNvit | TX | A1 | ST+S9_C0 | 15 | ATMCO2 | Atmospheric CO2 Percent | 5 | 15 | 123 | MNvit | TX | A1 | ST+S9_C0 | 16 | SPTOBID | Sponsor defined tobacco identifier | CIG01a | 16 | 123 | MNvit | TX | A1 | ST+S9_C0 | 17 | EXPTYP | | Submerged | 17 | 123 | MNvit | TX | A1 | ST+S9_C0 | 18 | SAMTYP | Sample Type | Total Particulate Matter in DMSO |
---|
18 | 123 | MNvit | TX | A1 | ST+S9_C0 | 19 | INTRVN | Name of the Intervention Article | Tobacco ProdA |
---|
19 | 123 | MNvit | TX | A1 | ST+S9_C0 | 20 | ITVTYPE | type of intervention article | Negative Control |
---|
20 | 123 | MNvit | TX | A1 | ST+S9_C0 | 21 | ITVCONC | Concentration of intervention article | 0 | 21 | 123 | MNvit | TX | A1 | ST+S9_C0 | 22 | ITVCONCU | Concentration Unit | ug/ml | 22 | 123 | MNvit | TX | A1 | ST+S9_C0 | 23 | SPDEVID | Sponsor defined device identifier | PUFFMASTER3K |
---|
23 | 123 | MNvit | TX | A1 | ST+S9_C0 | 24 | DUREFID | Smoke Regimen | Medium Intensity Regimen |
---|
24 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 2 | METACT | Metabolic Activation | +S9 |
---|
25 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 3 | METACTFL | Y/N presence of metabolic activation | Y |
---|
26 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 4 | TRTDMIN | Treatment Duration Minimum | 3 | 27 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 5 | TRTDTRG | Treatment Duration Target | 3.5 | 28 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 6 | TRTDMAX | Treatment Duration Maximum | 4 | 29 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 7 | TRTDU | Treatment Duration Unit | HOURS | 30 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 8 | RCVDMIN | Recovery Duration Minimum | 23.5 | 31 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 9 | RCVDTRG | Recovery Duration Target | 24 | 32 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 10 | RCVDMAX | Recovery Duration Maximum | 24.5 | 33 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 11 | RCVDU | Recovery Duration Unit | HOURS | 34 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 12 | INCBTMP | Incubation Temperature | 37 | 35 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 13 | INCBTMPU | Incubation Temperature Unit | C | 36 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 14 | HUMID | Atmospheric Relative Humidity Percent | 50 | 37 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 15 | ATMCO2 | Atmospheric CO2 Percent | 5 |
---|
38 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 16 | SPTOBID | Sponsor defined tobacco identifier | CIG01a |
---|
39 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 17 | EXPTYP | | Submerged |
---|
40 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 18 | SAMTYP | Sample Type | Total Particulate Matter in DMSO | 41 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 19 | INTRVN | Name of the Intervention Article | Tobacco ProdA | 42 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 20 | ITVTYPE | type of intervention article | Product |
---|
43 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 21 | ITVCONC | Concentration of intervention article | 1250 |
---|
44 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 22 | ITVCONCU | Concentration Unit | ug/ml |
---|
45 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 23 | SPDEVID | Sponsor defined device identifier | PUFFMASTER2023 |
---|
46 | 123 | MNvit | TX | A2 | ST+S9_C1250 | 24 | DUREFID | Smoke Regimen | High Intensity Regimen |
|
|
Dataset wrap |
---|
|
Rowcaps |
---|
Row 1: | Shows the value of REFID=C0, . This REFID refers to the trial set with a SETCD of 'A1', as defined in the trial set dataset, tx.xpt. LEVEL=1 and LVLDESC='EXPERIMENTAL UNIT/TRIAL SET' indicates this identifier relates is referring to the entire trial setboth the experimental unit, the unit to which the treatment is applied, and the entire trial set. | Rows 2-5: | Show the values of four observational units C0_Count1 through C0_Count4 that are within the parent experimental unit, REFID=C0, and in this example assay these observational units are also all within the same trial set, as defined in the trial set dataset, tx.xpt. | Rows 6: | Shows the value ...of REFID=C1250. This REFID refers to the trial set with a SETCD of 'A2', as defined in the trial set dataset, tx.xpt. LEVEL=1 and LVLDESC='EXPERIMENTAL UNIT/TRIAL SET' indicates this identifier is referring to both the experimental unit, the unit to which the treatment is applied, and the entire trial set. | Row 7-10: | Show the values of four observational units C1250_Count1 through C1250_Count4 that are within the parent experimental unit, REFID=C0, and in this example assay these observational units are also all within the same trial set, as defined in the trial set dataset, tx.xpt. | Row 7-10: | Show the values of four |
|
Dataset2 |
---|
| Row | STUDYID | GNTXAID | SETCD | REFID | PARENT | LEVEL | LVLDESC |
---|
1 | 123 | MNvit | A1 | C0 |
| 1 | EXPERIMENTAL UNIT/TRIAL SET |
---|
2 | 123 | MNvit | A1 | C0-Count1 | C0 | 2 | OBSERVATIONAL UNIT |
---|
3 | 123 | MNvit | A1 | C0-Count2 | C0 | 2 | OBSERVATIONAL UNIT |
---|
4 | 123 | MNvit | A1 | C0-Count3 | C0 | 2 | OBSERVATIONAL UNIT |
---|
5 | 123 | MNvit | A1 | C0-Count4 | C0 | 2 | OBSERVATIONAL UNIT |
---|
| C0 | 6 | 123 | MNvit | A2 | C1250 | 1 | EXPERIMENTAL UNIT/TRIAL SET | 7 | 123 | MNvit | A2 | C1250-Count1 | C1250 | 2 | OBSERVATIONAL UNIT8 |
---|
5 | 123 | MNvit | A2 A1 | C1250C0-Count2Count4C1250 | C0 | 2 | OBSERVATIONAL UNIT9 |
---|
6 | 123 | MNvit | A2C1250-Count3 | C1250 |
| 21OBSERVATIONAL | EXPERIMENTAL UNIT/TRIAL SET |
---|
107 | 123 | MNvit | A2 | C1250-Count4 | C1250 | 2 | OBSERVATIONAL UNIT |
|
|
A1: Image Removed
A2: Image Removed
Count1 | C1250 | 2 | OBSERVATIONAL UNIT | 8 | 123 | MNvit | A2 | C1250-Count2 | C1250 | 2 | OBSERVATIONAL UNIT | 9 |
|
|
Expand |
---|
|
|
Row | STUDYID | ASSAYID | DOMAIN | SETCD | EUID | OBUID |
1EIA1C0C1250 | 2 | OBSERVATIONAL UNIT | 10 | 123 | MNvit |
|
EI | A2 | C1250 | | A2 | C1250-Count4 | C1250 | 2 | OBSERVATIONAL UNIT |
|
A1: Image Added
A2: Image Added
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-5: | Show the number of revertant colonies per plate collected for each of five observational units ( REFID=0_1 through 0_5 as described in the relref dataset). | Rows 6, 7: | Show summary values collected (MEAN, STANDARD DEVIATION) for REFID=A that apply to the entire trial set, SetA, as indicated by LEVEL=1 and LVLDESC=TRIAL SET for this REFID in the relref dataset. | Rows 8-13: | Revertent colonies were counted for each of three plates/observational units (REFID=6_1 through 6_3) and each value is associated with a record to show a postfix code of "V" = "Very thin background bacterial lawn" | Rows 14-16: | Show summary values collected (MEAN, STANDARD DEVIATION, and FOLD INCREASE) for REFID=F that apply to the entire trial set, SetF, as indicated by LEVEL=1 and LVLDESC=TRIAL SET for this REFID in the relref dataset. | Rows 17-19: | Show three plates/observational units (REFID=5_1 through 5_3) where no revertant colonies were counted due to too much cytotoxicity and a postfix code of "T". | Rows 20-22: | Show the number of revertant colonies per plate collected for each of three observational units (REFID=18_1 through 18_3 as described in the relref dataset). | Rows 23-25: | Show summary values collected (MEAN, STANDARD DEVIATION, and FOLD INCREASE) for REFID=R that apply to the entire trial set, SetR, as indicated by LEVEL=1 and LVLDESC=TRIAL SET for this REFID in the relref dataset. |
|
Dataset2 |
---|
EUIDOBUID REFID | GTSEQ | GTTESTCD | GTTEST | GTCELLEV | GTORRES | GTORRESU | GTCOLSRT | GTSTRESC | GTSTRESN | GTSTRESU | GTDTC |
---|
1 | 123 | MNvit | GT | C0 | C0 | 1 | RICC | Relative Increase in Cell Count | 154 | 0 | % |
| 0 | 0 | % | 2022-05-25 | 2 | 123 | MNvit | GT | C0 | C0 | 2 | RCC | Relative Cell Count | 154 | 0 | % |
| 0 | 0 | % | 2022-05-25 | 3 | 123 | MNvit | GT | C0 | C0 | 3 | RPD | Relative Population Doubling | 154 | 0 | % |
| 0 | 0 | % | 2022-05-25 | 4 | 123 | MNvit | GT | C0 | C0-Count1 | 4 | MNCELLS | Micronucleated Cells | 2205 | 15 | Cells |
| 15 | 15 | Cells | 2022-05-25 | 5 | 123 | MNvit | GT | C0 | C0-Count2 | 5 | MNCELLS | Micronucleated Cells | 2474 | 13 | Cells |
| 13 | 13 | Cells | 2022-05-25 | 6 | 123 | MNvit | GT | C0 | C0-Count3 | 6 | MNCELLS | Micronucleated Cells | 2758 | 17 | Cells |
| 17 | 17 | Cells | 2022-05-25 | 7 | 123 | MNvit | GT | C0 | C0-Count4 | 7 | MNCELLS | Micronucleated Cells | 2669 | 12 | Cells |
| 12 | 12 | Cells | 2022-05-25 | 8 | 123 | MNvit | GT | C0 |
C0 | 8 | AVGREL | Average Relative MN Frequency |
| 0.57 | % |
| 0.57 | 0.57 | % | 2022-05-25 | 9 | 123 | MNvit | GT | C1250 | C1250 | 1 | RICC | Relative Increase in Cell Count | 134 | 15.7 | % |
| 15.7 | 15.7 | % | 2022-05-25 | 10 | 123 | MNvit | GT | C1250 | C1250 | 2 | RCC | Relative Cell Count | 134 | 13.0 | % |
| 13.0 | 13.0 | % | 2022-05-25 | 11 | 123 | MNvit | GT | C1250 | C1250 | 3 | RPD | Relative Population Doubling | 134 | 7.9 | % |
| 7.9 | 7.9 | % | 2022-05-25 | 12 | 123 | MNvit | GT | C1250 | C1250-Count1 | 4 | MNCELLS | Micronucleated Cells | 3266 | 20 | Cells |
| 20 | 20 | Cells | 2022-05-25 | 13 | 123 | MNvit | GT | C1250 | C1250-Count2 | 5 | MNCELLS | Micronucleated Cells | 2190 | 17 | Cells |
| 17 | 17 | Cells | 2022-05-25 | 14 | 123 | MNvit | GT | C1250 | C1250-Count3 | 6 | MNCELLS | Micronucleated Cells | 2758 | 13 | Cells |
| 13 | 13 | Cells | 2022-05-25 | 15 | 123 | MNvit | GT | C1250 | C1250-Count4 | 7 | MNCELLS | Micronucleated Cells | 2714 | 21 | Cells |
| 21 | 21 | Cells | 2022-05-25 | 16 | 123 | MNvit | GT | C1250 | C1250 | 8 | AVGREL | Average Relative MN Frequency |
| 0.66 | % |
| 0.66 | 0.66 | % | 2022-05-25 |
|
|